LYRM4 and central nervous system cancer: The Lasso analysis revealed that the expression of LINC01426, AC061992.2, CARD8-AS1, AC083855.2, AC027307.2, AC026356.1, LYRM4-AS1, WAKMAR2, and LINC02636 were associated with adverse survival time and DSS in patients with glioma.